Transgene Biotek secures USA patent on oral Insulin technology

09 Jan 2019 Evaluate

Transgene Biotek has been granted United State of America patent on technology for Oral delivery of Insulin and Insulin analogues.

This patent is a feather in the cap of Transgene Biotek's list of global patents. This intimation of patent being granted by USA will strengthen the company's management to justifiably increase its monetary value of its technology for oral delivery of Insulin and its analogues. With emergence of Insulin analogues across the globe from several large pharma companies, Transgene's oral delivery technology shall provide a new dimension for such molecules to deliver them through a convenient and increased patient compliant oral route.

Transgene Biotek (TBL) is engaged in manufacturing drugs.

Transgene Biotek Share Price

6.77 0.22 (3.36%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 344.50
Apollo Hospital Ent. 5837.15
Max Healthcare Inst 810.00
Narayana Hrudayalay 1260.00
Global Health 1410.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.